THE PATH TO BETTER Trademark

Trademark Overview

On Friday, January 11, 2019, a trademark application was filed for THE PATH TO BETTER with the United States Patent and Trademark Office. The USPTO has given the THE PATH TO BETTER trademark a serial number of 88258268. The federal status of this trademark filing is REGISTERED as of Tuesday, May 28, 2024. This trademark is owned by Toronto Autoimmunity and Oncology Inc. The THE PATH TO BETTER trademark is filed in the Treatment & Processing of Materials Services, Pharmaceutical Products, Advertising, Business and Retail Services, and Computer & Software Services & Scientific Services categories with the following description:

Custom manufacture of pharmaceuticals and therapeutic products being pharmaceuticals by pharmaceutical compounders

Pharmaceuticals for the treatment of cancer and auto-immune diseases; therapeutic products being small molecule, biologics, and cell therapies, namely, pharmaceutical preparations for the treatment and prevention of cancer and autoimmune diseases

Providing marketing services for the pharmaceutical and therapeutic products of others

Research and development in the field of pharmaceuticals and therapeutic products
the path to better

General Information

Serial Number88258268
Word MarkTHE PATH TO BETTER
Filing DateFriday, January 11, 2019
Status700 - REGISTERED
Status DateTuesday, May 28, 2024
Registration Number7394475
Registration DateTuesday, May 28, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 12, 2024

Trademark Statements

Goods and ServicesCustom manufacture of pharmaceuticals and therapeutic products being pharmaceuticals by pharmaceutical compounders
Goods and ServicesPharmaceuticals for the treatment of cancer and auto-immune diseases; therapeutic products being small molecule, biologics, and cell therapies, namely, pharmaceutical preparations for the treatment and prevention of cancer and autoimmune diseases
Goods and ServicesProviding marketing services for the pharmaceutical and therapeutic products of others
Goods and ServicesResearch and development in the field of pharmaceuticals and therapeutic products

Classification Information

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateMonday, September 30, 2019
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 1, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateMonday, September 30, 2019
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, February 1, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTREADWELL THERAPEUTICS CANADA INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressToronto, Ontario M5G2M9
CA
Party NameTREADWELL THERAPEUTICS CANADA INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressToronto, Ontario M5G2M9
CA
Party NameTREADWELL THERAPEUTICS CANADA INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressToronto, Ontario M5G2M9
CA
Party NameToronto Autoimmunity and Oncology Inc
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressOakville, ONTARIO L6J3R1
CA

Trademark Events

Event DateEvent Description
Tuesday, January 15, 2019NEW APPLICATION ENTERED
Friday, February 1, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 26, 2019ASSIGNED TO EXAMINER
Thursday, March 28, 2019NON-FINAL ACTION WRITTEN
Thursday, March 28, 2019NON-FINAL ACTION E-MAILED
Thursday, March 28, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, September 26, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, September 26, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, September 30, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 6, 2019SUSPENSION LETTER WRITTEN
Wednesday, November 6, 2019LETTER OF SUSPENSION E-MAILED
Wednesday, November 6, 2019NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, April 15, 2020AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, June 2, 2020ASSIGNED TO LIE
Monday, November 2, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, June 10, 2020REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, November 2, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, November 2, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, November 2, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, November 2, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, June 26, 2021SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Friday, July 9, 2021SUSPENSION INQUIRY WRITTEN
Friday, July 9, 2021INQUIRY TO SUSPENSION E-MAILED
Friday, July 9, 2021NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Friday, July 9, 2021TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, July 14, 2021ASSIGNED TO LIE
Friday, July 16, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, July 16, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, July 16, 2021SUSPENSION LETTER WRITTEN
Friday, July 16, 2021LETTER OF SUSPENSION E-MAILED
Friday, July 16, 2021NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, November 4, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, November 4, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, November 4, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, February 7, 2022SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Wednesday, February 16, 2022INQUIRY TO SUSPENSION E-MAILED
Wednesday, February 16, 2022SUSPENSION INQUIRY WRITTEN
Wednesday, February 16, 2022NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Friday, August 12, 2022TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, August 16, 2022ASSIGNED TO LIE
Wednesday, August 17, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 17, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 17, 2022SUSPENSION LETTER WRITTEN
Wednesday, August 17, 2022LETTER OF SUSPENSION E-MAILED
Wednesday, August 17, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, January 20, 2023ASSIGNED TO EXAMINER
Tuesday, March 28, 2023SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Friday, April 21, 2023SUSPENSION INQUIRY WRITTEN
Friday, April 21, 2023INQUIRY TO SUSPENSION E-MAILED
Friday, April 21, 2023NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Thursday, July 6, 2023TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, July 6, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 10, 2024SUSPENSION INQUIRY WRITTEN
Thursday, July 6, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, July 13, 2023SUSPENSION LETTER WRITTEN
Thursday, July 13, 2023LETTER OF SUSPENSION E-MAILED
Thursday, July 13, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, January 10, 2024INQUIRY TO SUSPENSION E-MAILED
Wednesday, January 10, 2024NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Friday, January 26, 2024TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, January 29, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 29, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 29, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 21, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, February 21, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 12, 2024PUBLISHED FOR OPPOSITION
Tuesday, March 12, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 28, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, May 28, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED

Related Keywords

better path products therapeutic pharmaceuticals pharmaceutical cancer diseases treatment being marketing providing